DEBRA Research, Dermaliq Team Up to Advance Cutaneous Drug Delivery for EB
DEBRA Research gGmbH and Dermaliq Therapeutics, Inc. are joining forces to advance cutaneous drug delivery into the skin for Epidermolysis Bullosa (EB).
Category: Rare Diseases